Search research articles
Contact Us
Filters
Showing results (401-410 of 424) with videos related to
Page
of 43
Sort By:
Global Health Action
|
November 8, 2014
Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites
P Kim Streatfield, Wasif A Khan, Abbas Bhuiya, et al.
Lancet (London, England)
|
September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
John J Aponte, David Schellenberg, Andrea Egan, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites
Seif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.
Malaria Journal
|
March 25, 2022
Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea
Maxmillian Mpina, Thomas C Stabler, Tobias Schindler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
Ally Olotu, Vicente Urbano, Ali Hamad, et al.
Vaccine
|
November 12, 2019
Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
Lucas Otieno, Yolanda Guerra Mendoza, Samuel Adjei, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian Adults
Said A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The Journal of Infectious Diseases
|
August 26, 2010
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization
Selidji T Agnandji, Kwaku Poku Asante, John Lyimo, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 424) with videos related to
Sort By:
Page
of 43
Global Health Action
|
November 8, 2014
Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites
P Kim Streatfield, Wasif A Khan, Abbas Bhuiya, et al.
Lancet (London, England)
|
September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
John J Aponte, David Schellenberg, Andrea Egan, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 30, 2014
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites
Seif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, et al.
Malaria Journal
|
March 25, 2022
Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea
Maxmillian Mpina, Thomas C Stabler, Tobias Schindler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
Ally Olotu, Vicente Urbano, Ali Hamad, et al.
Vaccine
|
November 12, 2019
Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
Lucas Otieno, Yolanda Guerra Mendoza, Samuel Adjei, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of <i>Plasmodium falciparum</i> Sporozoite Vaccine in Tanzanian Adults
Said A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
Said A Jongo, L W Preston Church, Ali T Mtoro, et al.
The Journal of Infectious Diseases
|
August 26, 2010
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization
Selidji T Agnandji, Kwaku Poku Asante, John Lyimo, et al.
Page
of 43